Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30050713HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050714HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050715HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS30050716HIVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20001223HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20054272HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS20026602HPVENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44004968HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44011985HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TVIS44011854HTLV-1ENSG00000115353.11protein_codingTACR1NoNo6869P25103
TCGA Plot Options
Drug Information
GeneTACR1
DrugBank IDDB04894
Drug NameVapreotide
Target IDBE0000384
UniProt IDP25103
Regulation Typeantagonist
PubMed IDs7556407; 11752352
CitationsBetoin F, Advenier C, Fardin V, Wilcox G, Lavarenne J, Eschalier A: In vitro and in vivo evidence for a tachykinin NK1 receptor antagonist effect of vapreotide, an analgesic cyclic analog of somatostatin. Eur J Pharmacol. 1995 Jun 12;279(2-3):241-9.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsExperimental; Investigational
Direct ClassificationOligopeptides
SMILESCC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(N)=O)NC(=O)[C@H](N)CC1=CC=CC=C1
Pathways
PharmGKBPA164743146
ChEMBLCHEMBL3349523